151 related articles for article (PubMed ID: 10555937)
21. Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey.
Tezcan G; Kupesiz A; Ozturk F; Ogunc D; Gultekin M; Yesilipek A; Hazar V
Pediatr Hematol Oncol; 2006; 23(3):217-29. PubMed ID: 16517538
[TBL] [Abstract][Full Text] [Related]
22. [Microbiological isolates in patients with febrile neutropenia and hematological neoplasias].
Figuera Esparza M; Carballo M; Silva M; Figueredo A; Avilán J
Rev Esp Quimioter; 2006 Sep; 19(3):247-51. PubMed ID: 17099792
[TBL] [Abstract][Full Text] [Related]
23. Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial.
Attal M; Schlaifer D; Rubie H; Huguet F; Charlet JP; Bloom E; Lemozy J; Massip P; Pris J; Laurent G
J Clin Oncol; 1991 May; 9(5):865-70. PubMed ID: 2016630
[TBL] [Abstract][Full Text] [Related]
24. [Febrile neutropenia: empiric antibiotic therapy from 1975 to 1997].
Klastersky J
Rev Med Brux; 1997 Oct; 18(5):323-7. PubMed ID: 9441328
[TBL] [Abstract][Full Text] [Related]
25. Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer.
Shenep JL; Hughes WT; Roberson PK; Blankenship KR; Baker DK; Meyer WH; Gigliotti F; Sixbey JW; Santana VM; Feldman S
N Engl J Med; 1988 Oct; 319(16):1053-8. PubMed ID: 3050517
[TBL] [Abstract][Full Text] [Related]
26. Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.
Mustafa MM; Carlson L; Tkaczewski I; McCracken GH; Buchanan GR
Pediatr Infect Dis J; 2001 Mar; 20(3):362-9. PubMed ID: 11303851
[TBL] [Abstract][Full Text] [Related]
27. Management of the febrile neutropenic patient.
Picazo JJ;
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S120-2; discussion S133-40. PubMed ID: 16243492
[TBL] [Abstract][Full Text] [Related]
28. Initial empiric therapy for fever in neutropenia.
Bustamante CI
Recent Results Cancer Res; 1993; 132():45-56. PubMed ID: 8265870
[No Abstract] [Full Text] [Related]
29. Clinical implications of icaA and icaD genes in coagulase negative staphylococci and Staphylococcus aureus bacteremia in febrile neutropenic pediatric cancer patients.
El-Mahallawy HA; Loutfy SA; El-Wakil M; El-Al AK; Morcos H
Pediatr Blood Cancer; 2009 Jul; 52(7):824-8. PubMed ID: 19214976
[TBL] [Abstract][Full Text] [Related]
30. Withholding initial vancomycin in febrile neutropenia despite implanted catheters.
Berger C; Kindli K; Niggli FK; Nadal D
Eur J Pediatr; 2004 Jul; 163(7):422-3. PubMed ID: 15141312
[No Abstract] [Full Text] [Related]
31. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KV; Ramsey SD
J Clin Oncol; 2013 Feb; 31(6):794-810. PubMed ID: 23319691
[TBL] [Abstract][Full Text] [Related]
32. The role of teicoplanin in the treatment of febrile neutropenia.
Menichetti F
J Chemother; 2000 Nov; 12 Suppl 5():34-9. PubMed ID: 11131962
[TBL] [Abstract][Full Text] [Related]
33. Ceftazidime plus amikacin plus teicoplanin or vancomycin in the empirical antibiotic therapy in febrile neutropenic cancer patients.
Nucci M; Biasoli I; Braggio S; Portugal R; Schaffel R; Maiolino A; Loureiro MM; Spector N; Pulcheri W
Oncol Rep; 1998; 5(5):1205-9. PubMed ID: 9683836
[TBL] [Abstract][Full Text] [Related]
34. Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and gram-positive bacteremia.
Sidi V; Roilides E; Bibashi E; Gompakis N; Tsakiri A; Koliouskas D
J Chemother; 2000 Aug; 12(4):326-31. PubMed ID: 10949982
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of febrile, nonneutropenic pediatric oncology patients with central venous catheters who are not given empiric antibiotics.
Bartholomew F; Aftandilian C; Andrews J; Gutierrez K; Luna-Fineman S; Jeng M
J Pediatr; 2015 Jan; 166(1):157-62. PubMed ID: 25444524
[TBL] [Abstract][Full Text] [Related]
36. [Microbiological characteristics of pathogens causing bacteremia among hospitalized pediatric oncology patients with fever and neutropenia].
Leibson T; Ben-Shimol S; Hazan G; Fruchtman Y; Kapelushnik J; Greenberg D
Harefuah; 2012 Oct; 151(10):592-6, 603-4. PubMed ID: 23316669
[TBL] [Abstract][Full Text] [Related]
37. Antibiotic management of febrile neutropenia: current developments and future directions.
Mebis J; Goossens H; Berneman ZN
J Chemother; 2010 Feb; 22(1):5-12. PubMed ID: 20227985
[TBL] [Abstract][Full Text] [Related]
38. The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategies.
Pizzo PA; Rubin M; Freifeld A; Walsh TJ
J Pediatr; 1991 Nov; 119(5):679-94. PubMed ID: 1941374
[No Abstract] [Full Text] [Related]
39. Neutropenic Fever.
White L; Ybarra M
Hematol Oncol Clin North Am; 2017 Dec; 31(6):981-993. PubMed ID: 29078933
[TBL] [Abstract][Full Text] [Related]
40. A prospective study of cefepime versus ticarcilline/clavulanate as empirical treatment of febrile neutropenia in lymphoma patients.
Naseem A; Hussain Y; Ahmad B; Aziz MT; Ahmad M; Hameed H
J Pak Med Assoc; 2011 Jan; 61(1):18-22. PubMed ID: 22368896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
